HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yourong Duan Selected Research

Platinum

1/2022Nano-ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy.
1/2020Nanoparticle BAF312@CaP-NP Overcomes Sphingosine-1-Phosphate Receptor-1-Mediated Chemoresistance Through Inhibiting S1PR1/P-STAT3 Axis in Ovarian Carcinoma.
10/2019Dual-mode US/MRI nanoparticles delivering siRNA and Pt(iv) for ovarian cancer treatment.
1/2019GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yourong Duan Research Topics

Disease

57Neoplasms (Cancer)
03/2024 - 03/2008
10Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2014
8Neoplasm Metastasis (Metastasis)
01/2023 - 02/2019
8Triple Negative Breast Neoplasms
11/2022 - 02/2019
7Breast Neoplasms (Breast Cancer)
01/2022 - 02/2010
7Prostatic Neoplasms (Prostate Cancer)
01/2022 - 04/2015
6Hepatocellular Carcinoma (Hepatoma)
10/2019 - 02/2010
4Carcinoma (Carcinomatosis)
10/2021 - 06/2012
3Liver Neoplasms (Liver Cancer)
03/2024 - 11/2016
3Atherosclerosis
01/2023 - 04/2017
3Stomach Neoplasms (Stomach Cancer)
10/2021 - 06/2012
3Hemolysis
03/2015 - 02/2014
2Inflammation (Inflammations)
01/2023 - 01/2022
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2021
2Hypoxia (Hypoxemia)
02/2022 - 07/2021
2Colonic Neoplasms (Colon Cancer)
02/2019 - 01/2012
2Lung Neoplasms (Lung Cancer)
10/2016 - 10/2009
2Glioblastoma (Glioblastoma Multiforme)
04/2016 - 12/2015
1Nose Diseases (Disease, Nose)
02/2024
1Allergic Rhinitis
02/2024

Drug/Important Bio-Agent (IBA)

10methoxypolyethyleneglycol- poly(lactic- co- glycolic acid)IBA
02/2019 - 06/2012
8Paclitaxel (Taxol)FDA LinkGeneric
03/2021 - 06/2013
7Proteins (Proteins, Gene)FDA Link
01/2023 - 02/2014
7Contrast MediaIBA
01/2023 - 01/2019
7monomethoxypolyethylene glycol (MPEG)IBA
11/2022 - 01/2012
7Small Interfering RNA (siRNA)IBA
10/2021 - 06/2012
6Peptides (Polypeptides)IBA
01/2022 - 06/2012
5LigandsIBA
01/2023 - 01/2021
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 06/2012
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2013
5Therapeutic UsesIBA
01/2021 - 12/2015
5calcium phosphateIBA
06/2020 - 01/2013
4AntigensIBA
01/2023 - 04/2015
4Liposomes (Liposome)IBA
01/2023 - 07/2013
4PlatinumIBA
01/2022 - 01/2019
4Epidermal Growth Factor (EGF)IBA
10/2021 - 05/2013
4triptolideIBA
03/2021 - 11/2017
4monomethoxy (polyethylene glycol)- poly(lactide- co- glycolide)- poly(lysine)IBA
10/2016 - 06/2012
3LipidsIBA
01/2023 - 07/2013
3CytokinesIBA
01/2023 - 01/2015
3Ethylene Glycol (Monoethylene Glycol)IBA
11/2022 - 06/2013
3Dexamethasone (Maxidex)FDA LinkGeneric
02/2022 - 04/2017
31,2-distearoylphosphatidylethanolamine (DSPE)IBA
05/2021 - 01/2020
3Phosphates (Orthophosphate)IBA
05/2021 - 10/2009
3IonsIBA
05/2021 - 11/2019
3Mitoxantrone (Novantrone)FDA LinkGeneric
12/2019 - 11/2008
3EmulsionsIBA
02/2019 - 06/2012
3PolymersIBA
01/2019 - 11/2008
3ErbB Receptors (EGF Receptor)IBA
03/2018 - 02/2010
3polyethylene glycol-poly(lactide-co-glycolide)IBA
12/2015 - 01/2014
3poly(lactide) (polylactic acid)IBA
06/2013 - 02/2010
3Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2013 - 11/2008
3mPEG-PLGA-PLL-cRGDIBA
10/2012 - 01/2012
3Lysine (L-Lysine)FDA Link
01/2012 - 02/2010
2Amyloid (Amyloid Fibrils)IBA
01/2023 - 01/2021
2B7-H1 AntigenIBA
01/2023 - 07/2021
2Sirolimus (Rapamycin)FDA Link
01/2023 - 06/2020
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2023 - 01/2022
2Death Domain ReceptorsIBA
01/2023 - 01/2021
2P-SelectinIBA
01/2023 - 01/2022
2Arsenic Trioxide (Trisenox)FDA Link
01/2023 - 01/2019
2MicellesIBA
01/2023 - 02/2022
2osimertinibIBA
01/2023 - 01/2021
21-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2022 - 07/2021
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2022 - 05/2021
2SolutionsIBA
01/2022 - 11/2019
2ProdrugsIBA
01/2022 - 01/2019
2human ERBB2 proteinIBA
07/2021 - 01/2013
2siponimodIBA
05/2021 - 01/2020
2CalciumIBA
05/2021 - 01/2020
21,2- distearoyl- sn- glycero- 3- phosphoethanolamine- N- methoxy- poly(ethylene glycol 2000)IBA
05/2021 - 01/2020
2Glutathione (Reduced Glutathione)IBA
02/2021 - 01/2019
2HydrogelsIBA
06/2020 - 11/2016
2DNA (Deoxyribonucleic Acid)IBA
10/2019 - 10/2016
2NanogelsIBA
10/2019 - 07/2017
2bufalinIBA
02/2019 - 01/2012
2MicroRNAs (MicroRNA)IBA
09/2018 - 03/2018
2Poloxamer (Poloxamer 407)IBA
11/2016 - 01/2013
2Temozolomide (Temodar)FDA LinkGeneric
04/2016 - 12/2015
2Fluorouracil (Carac)FDA LinkGeneric
07/2014 - 06/2012
2ChitosanIBA
07/2013 - 01/2013
2Glycine (Aminoacetic Acid)FDA LinkGeneric
06/2012 - 12/2011
2Arginine (L-Arginine)FDA Link
06/2012 - 12/2011
2Drug CarriersIBA
01/2012 - 03/2008
1Immunologic Factors (Immunomodulators)IBA
03/2024
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2024
1Nasal SpraysIBA
02/2024
1Butyryl-CoA Dehydrogenase (Short-Chain Acyl-CoA Dehydrogenase)IBA
01/2023
1EnzymesIBA
01/2023

Therapy/Procedure

27Therapeutics
03/2024 - 03/2008
18Drug Therapy (Chemotherapy)
03/2024 - 02/2010
5Microbubbles
01/2021 - 12/2015
4Immunotherapy
03/2024 - 11/2022
4Intravenous Injections
01/2023 - 07/2013
4Precision Medicine
02/2022 - 01/2019
3Lasers (Laser)
06/2014 - 02/2010
2Photothermal Therapy
01/2023 - 09/2019
2Photochemotherapy (Photodynamic Therapy)
02/2022 - 07/2021
2Nanospheres
02/2019 - 03/2015
1Injections
02/2024